| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 11/06/2008 | US20080274139 Attenuated microorganisms for the treatment of infection |
| 11/06/2008 | US20080274138 leads to higher yields and reduces unwanted aggregation of the virus or virus antigen by increasing the volume of the peak pool |
| 11/06/2008 | US20080274137 to improve expression of exogenous polypeptides, such as antigen, epitope, immunogen, peptide or polypeptide of interest; insertion of transposon between kanamycin resistance gene promoter and translation initiation abolished kanamycin resistance and unexpectedly enabled high rates of plasmid replication |
| 11/06/2008 | US20080274136 Polyvalent Attenuated Live Vaccine For Preventing and Curing Vibriosis of Cultivated Fish |
| 11/06/2008 | US20080274135 Measuring Degree of Polymerisation for Meningococcal Capsular Saccharides That Contain Sialic Acid |
| 11/06/2008 | US20080274134 for preventing a subject from becoming infected with HIV-1; or delaying the onset of, or slowing the rate of progression of |
| 11/06/2008 | US20080274133 Soluble Bifunctional Proteins |
| 11/06/2008 | US20080274132 Vaccines for blocking transmission of plasmodium vivax |
| 11/06/2008 | US20080274131 Molecular antigen arrary |
| 11/06/2008 | US20080274130 Rabies Virus Vector Systems and Compositions and Methods Thereof |
| 11/06/2008 | US20080274129 Hla-A2 Tumor Associated Antigen Peptides and Compositions |
| 11/06/2008 | US20080274128 Heat shock protein-based vaccines and immunotherapies |
| 11/06/2008 | US20080274127 Using probiotic nutrient mix comprising synthetic peptides, free amino acids and/or protein hydrolysates as therapeutic in treatment of gastrointestinal distress and to enhance immune system response |
| 11/06/2008 | US20080274126 Oral Vaccines for Fish |
| 11/06/2008 | US20080274125 Human Stem Cell Lines Derived From Es Cells and Uses for Production of Vaccines and Recombinant Proteins |
| 11/06/2008 | US20080274124 Polyunsaturated fatty acids; kits |
| 11/06/2008 | US20080274123 Synaptic vesicle glycoprotein specific immunoglobulin for use in treatment and prevention of liver disorders; tissue targeted therapy |
| 11/06/2008 | US20080274122 Plks as Modifiers of the Beta Catenin Pathway and Methods of Use |
| 11/06/2008 | US20080274121 Inhibition of Angiogenesis by Mithramycin |
| 11/06/2008 | US20080274119 Use of Opioid Antagonists to Attenuate Endothelial Cell Proliferation and Migration |
| 11/06/2008 | US20080274118 CD40 specific immunoglobulin for prevention and treatment of arthritic, cardiovascular, allergic, neurodegenerative and/or blood disorders |
| 11/06/2008 | US20080274117 Using monoclonal antibody specific to testis-specific serine kinase (TSSK) as tool in controlling reproduction |
| 11/06/2008 | US20080274116 Lipids, Lipid Complexes and Use Thereof |
| 11/06/2008 | US20080274115 Human estrogen specific immunoglobulin for use as evaluative tool in diagnosing/prognosing metastatic cancers; evaluating efficacy of anticancer treatment |
| 11/06/2008 | US20080274114 Anti-Egfr Antibodies |
| 11/06/2008 | US20080274113 Immunoglobulin specific to actin-myosin machinery of malarial parasite; prevention protozoal diseases |
| 11/06/2008 | US20080274112 Axonal growth receptor for use in designing immunoglobulins for prevention and treatment of nervous system, cardiovascular, vision and/or spinal cord injury |
| 11/06/2008 | US20080274111 Pancreatic Cancer Genes |
| 11/06/2008 | US20080274110 Minibodies for use in treatment and prevention of cell proliferative and/or autoimmune disorders |
| 11/06/2008 | US20080274109 Nucleotide sequences coding chemokines for use in dianosis of infection, arteriosclerosis, autoimmune, inflammatory, allergic and arthritic disorders |
| 11/06/2008 | US20080274108 Polypeptide variants with altered effector function |
| 11/06/2008 | US20080274107 Tyrosine kinase inhibitors |
| 11/06/2008 | US20080274106 Using interleukin-6 specific monoclonal antibody as therapeutic in treatment and prevention of lung cancer |
| 11/06/2008 | US20080274105 Polypeptide variants with altered effector function |
| 11/06/2008 | US20080274104 Targeting a Secreted Pro-Apoptotic Factor for Cancer Therapeutics |
| 11/06/2008 | US20080274103 Adenylyl Cyclase Antibodies, Compositions and Uses Thereof |
| 11/06/2008 | US20080274102 Antibodies to Nik, Their Preparation and Use |
| 11/06/2008 | US20080274101 Stabilizing polypeptides which have been exposed to urea |
| 11/06/2008 | US20080274100 Chemokine receptors CCR5 or CXCR4 specific immunoglobulins for use in prevention and treatment of human immunodeficiency syndrome viral infection |
| 11/06/2008 | US20080274099 Oncofoetal domain specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 11/06/2008 | US20080274098 Method of Treating or Preventing Tissue Deterioration, Injury or Damage Due to a Neuro-, Muscular- or Neuro-Muscular-Degenerative Disease, or Restore Tissue Adversely Affected by Said Disease |
| 11/06/2008 | US20080274077 Using Nogo receptor suppressant as therapeutic in treatment of nervous system and neurodegenerative disorders; axonal regeneration |
| 11/06/2008 | US20080274059 Mite fusion proteins |
| 11/06/2008 | US20080274057 Staudinger Reaction in Imaging and Therapy and Kits for Use in Imaging and Therapy |
| 11/06/2008 | US20080274055 retain binding affinity for carcinoembryonic antigen; immunogenicity, compared to a parent antibody; vectors; host cells |
| 11/06/2008 | US20080274049 Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 11/06/2008 | US20080274047 producing antibodies which bind NK cell receptors for use in therapeutic strategies for treating immunoproliferative and autoimmune disorders |
| 11/06/2008 | US20080274045 Imaging, diagnosis and treatment of disease |
| 11/06/2008 | US20080273660 Compositions and Methods for Modulating DNA Repair |
| 11/06/2008 | DE102007020254A1 Use of an agent reducing the bioavailability of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to prepare a medicament, especially for treating allergic diseases |
| 11/06/2008 | CA2685584A1 Cytotoxic anti-lag-3 monoclonal antibody and its use in the treatment or prevention of organ transplant rejection and autoimmune disease |
| 11/06/2008 | CA2685558A1 Trypanosoma antigens, vaccine compositions, and related methods |
| 11/06/2008 | CA2685522A1 High viscosity macromolecular compositions for treating ocular conditions |
| 11/06/2008 | CA2685341A1 Macrophage transfection method |
| 11/06/2008 | CA2685170A1 Prrsv gp5 based compositions and methods |
| 11/06/2008 | CA2685136A1 Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90 |
| 11/06/2008 | CA2685132A1 Combinations of gene deletions for live attenuated shigella vaccine strains |
| 11/06/2008 | CA2685125A1 Adjuvant combinations comprising an nkt activator, a cd40 agonist, and optionally an antigen and use thereof for inducing a synergistic enhancement in cellular immunity |
| 11/06/2008 | CA2685124A1 Products for altering il-33 activity and methods therefor |
| 11/06/2008 | CA2685099A1 Antibodies against ramp3 |
| 11/06/2008 | CA2685015A1 Anti-mdl-1 antibodies |
| 11/06/2008 | CA2683888A1 Chlamydial antigens as reagents for diagnosis and treatment of chlamydial infection and disease |
| 11/06/2008 | CA2683145A1 Antagonists to il-17a, il-17f, and il-23p19 and methods of use |
| 11/06/2008 | CA2682889A1 Antibodies that bind both il-17a and il-17f and methods of using the same |
| 11/06/2008 | CA2676809A1 Immediate protection against pathogens via mva |
| 11/06/2008 | CA2676808A1 Induction of dendritic cell development with macrophage-colony stimulating factor (m-csf) |
| 11/06/2008 | CA2667989A1 Antagonists of pcsk9 |
| 11/06/2008 | CA2666974A1 Fully human anti-vegf antibodies and methods of using |
| 11/05/2008 | EP1988162A1 Monoclonal antibody, gene encoding the antibody, hybridoma, pharmaceutical composition, and diagnostic reagent |
| 11/05/2008 | EP1988102A1 Growth factor homolog ZVEGF3 |
| 11/05/2008 | EP1988097A1 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 11/05/2008 | EP1987843A2 Method for solubilising peptide mixtures |
| 11/05/2008 | EP1987842A1 Cell proliferation inhibitor |
| 11/05/2008 | EP1987841A1 Use of a lipopeptide or lipoprotein as adjuvans in therapeutic or prophylactic vaccination |
| 11/05/2008 | EP1987840A1 Prime-boost vaccine for the protection of equines against viral infection |
| 11/05/2008 | EP1987839A1 Cytotoxic anti-LAG-3 monoclonal antibody and its use in the treatment or prevention of organ transplant rejection and autoimmune disease |
| 11/05/2008 | EP1987836A1 Protective staphylococcus aureus vaccine based on cell wall-associated proteins |
| 11/05/2008 | EP1987151A2 Lipoparticles comprising ion channels, methods of making, and using the same |
| 11/05/2008 | EP1987138A1 Cytotoxicity mediation of cells evidencing surface expression of cd63 |
| 11/05/2008 | EP1987067A2 Antibody formulation |
| 11/05/2008 | EP1987066A2 Methods for treating autoimmune or demyelinating diseases |
| 11/05/2008 | EP1987065A2 Methods for improving immune function and methods for prevention or treatment of disease in a mammalian subject |
| 11/05/2008 | EP1987064A1 Domain antibody construct |
| 11/05/2008 | EP1986698A2 Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders |
| 11/05/2008 | EP1986690A2 ANTI-FcRn ANTIBODIES FOR TREATEMENT OF AUTO/ALLO IMMUNE CONDITIONS |
| 11/05/2008 | EP1986689A2 Compositions and methods for treating haematological proliferative disorders |
| 11/05/2008 | EP1986687A1 Destruction of tumor cells expressing low to medium levels of tumor associated target antigens by trifunctional bispecific antibodies |
| 11/05/2008 | EP1986686A2 A dengue reporter virus and methods of making and using the same |
| 11/05/2008 | EP1986685A2 Vaccine delivery compositions and methods of use |
| 11/05/2008 | EP1986684A2 Functional antibodies |
| 11/05/2008 | EP1986632A1 Combinations comprising a cdk inhibitor and a growth factor antibody or anti-mitotic |
| 11/05/2008 | EP1646720B1 Antibodies against insulin-like growth factor i receptor and uses thereof |
| 11/05/2008 | EP1355634B1 Sn-38 lipid complexes and methods of use |
| 11/05/2008 | EP1233782B1 Eliciting hcv-specific antibodies |
| 11/05/2008 | EP1196193B1 Interleukin-1 mutein useful as vaccine adjuvant |
| 11/05/2008 | EP1150712B1 Human papilloma virus vaccine formulations |
| 11/05/2008 | EP1140172B1 The prevention and treatment for retinal ischemia and edema |
| 11/05/2008 | EP1109937B1 METHOD OF DIAGNOSING, MONITORING, STAGING, and IMAGING VARIOUS CANCERS |
| 11/05/2008 | EP0994724B1 Methods and compositions for impairing multiplication of hiv-1 |
| 11/05/2008 | CN101300355A Chimeric antigen containing hepatitis c virus polypeptide and Fc fragment for eliciting an immune response |